Ph.D., CEO, BioMADE
Biography
Douglas Friedman is CEO of BioMADE, the Bioindustrial Manufacturing Innovation Institute. His interests lie in the fields of synthetic biology, bioindustrial manufacturing, and biotechnology as they relate to the development of the bioeconomy. He is a subject matter expert on emerging biotechnologies, biotechnology policy, and related national security topics. He is a member of several advisory groups including the Department of Commerce, Bureau of Industry & Security Materials and Equipment Technical Advisory Committee. Prior to BioMADE, Doug was the inaugural Executive Director of Engineering Biology Research Consortium (EBRC) and currently serves on its Steering Committee. He earned a Ph.D. in Chemistry from Northwestern University and a B.S. in Chemical Biology from the University of California, Berkeley.
Session Abstract – PMWC 2023 Silicon Valley
Track 4 - January 25 9.00 A.M.-4.45 P.M.
Track Chair: Cindy Lawley, Olink
- How New Public-Private Collaboratives Can Catalyze Transformative Health Breakthroughs
Chair: Keith Yamamoto, UCSF
- Douglas Friedman, Engineering Biology Research Consortium (EBRC)
- Jay Keasling, JBEI (Joint BioEnergy Institute)
- Renee Wegrzyn, ARPA-H - Moving Sequencing into the Clinical Setting
Chair: Charles Chiu, UCSF
- Charlotte Hobbs, Rady Children’s Hospital
- Euan Ashley, Stanford University
- Sivan Bercovici, Karius
- Heike Sichtig, Foundation Medicine - Evolving Sequencing Applications: Spatial Single-Cell Multi-Omics
Chair: Michael Rhodes, NanoString
- Chrstina Curtis, Stanford - How will Cheap Genome Sequencing Impact Genomic Medicine (PANEL)
Chair: Euan Ashley, Stanford
- Shawn Levy, Element Biosciences
- Aleks Rajkovic, UCSF
- David Bentley, Illumina
- Stacey Gabriel, Broad Inst.
- Sean Hofherr, Fabric Genomics - Single-cell, Spatial, and in Situ Technologies
Chair: Dina Finan, 10x Genomics
- Carina Emery, Miltenyi Biotec - Combining WGS with a AI-based Tumor Enrichment Method
Chair: Asaf Zviran, C2I
- Multi-omics Approaches Supporting Clinical Translation
Chair: Cindy Lawley, Olink
- Erin Smith, Takeda
- Si Wu, Stanford
- Christopher Whelan, J&J - Molecular Diagnosis New standard with NGS for Neurological and Infectious Conditions
Chair: Scott Rabuka, DNA Genotek
- Forrest Wright, Quadrant Laboratories
- Frank Middleton, SUNY Upstate Medical University - PMWC Showcase
- Josh Lauer, Ultime
- Olivier Lucas, Oxford Nanopore
- Lukasz Boryn, Ardigen
